查詢結果分析
相關文獻
- 胰臟癌藥物治療進展
- Malignant Primary Extragonadal Germ Cell Tumors of Mediastinum--An Analysis of Clinical and Radiological Features in 15 Cases
- Uterine Papillary Serous Carcinoma Involving the Benign Cystic Teratoma of Ovary: An Unusual Case Report and Review of Literature
- 卵巢癌婦女接受手術和化學治療經驗中的行為反應
- Carcinosarcoma of the Ovary: A Case Report
- The Result of Treatment for Locally Recurrent Rectal Cancer
- Post-Operative Combination of Radiotherapy and Chemotherapy in Esophageal Cancer
- 胰臟癌化學治療
- 肺癌胗斷與治療
- Krukenberg Tumor:Analysis of 15 Cases--Surgery, Chemotherapy, Prognosis
頁籤選單縮合
題 名 | 胰臟癌藥物治療進展=Progress in the Medical Treatment of Pancreatic Cancer |
---|---|
作 者 | 徐秉裕; 蘇慧真; | 書刊名 | 藥學雜誌 |
卷 期 | 34:2=135 2018.06[民107.06] |
頁 次 | 頁2-8 |
分類號 | 418.31 |
關鍵詞 | 胰臟癌; 手術; 化學治療; |
語 文 | 中文(Chinese) |
中文摘要 | 近年來癌症人數逐年升高,胰臟癌位居國內十大癌症之一,針對胰臟癌的治療, 外科手術及化學治療扮演了很重要的角色,但胰臟癌的預後不佳,整體來說患者五年 存活率不到5%,手術切除是治癒的唯一機會,但超過80%的病人無法在初期被診斷且 切除,雖然目前有很多藥物 (單一藥物或是合併藥物) 用於治療胰臟癌但療效不一,期 待未來有更多的臨床試驗能更進一步的證實哪種藥物或組合,對於延長胰臟癌病人存 活率是最有效益,以提供臨床照護最好的選擇。 |
英文摘要 | The incidence of cancer has been steadily increasing over the last few decades. Pancreatic cancer is one of the top 10 cancer that causes death in Taiwan. The current treatment options for pancreatic cancer are surgery and chemotherapy. Pancreatic cancer often has a poor prognosis and the 5-year survival rate is less than 5%. Surgical resection is the only potentially curative technique for managing pancreatic cancer. However, more than 80% of patients present with disease that cannot be cured with surgical resection. Although single-agent and the combination chemotherapy have been the treatment choices for pancreatic cancer, the options do not show the same clinical benefit. It is expected that more clinical trials in the future will further confirm which drugs or combinations are most effective in prolonging the survival rate of pancreatic cancer and provide patients the best choice for clinical care. |
本系統中英文摘要資訊取自各篇刊載內容。